These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 2354868
1. Release of platelet-activating factor in systemic lupus erythematosus. Tetta C, Bussolino F, Modena V, Montrucchio G, Segoloni G, Pescarmona G, Camussi G. Int Arch Allergy Appl Immunol; 1990; 91(3):244-56. PubMed ID: 2354868 [Abstract] [Full Text] [Related]
2. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Stafforini DM, Carter ME, Zimmerman GA, McIntyre TM, Prescott SM. Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339 [Abstract] [Full Text] [Related]
3. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency. Surya II, Mommersteeg M, Erkelens DW, Akkerman JW. J Lipid Mediat; 1991 Apr; 3(1):27-38. PubMed ID: 1768838 [Abstract] [Full Text] [Related]
4. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. Stafforini DM, McIntyre TM, Carter ME, Prescott SM. J Biol Chem; 1987 Mar 25; 262(9):4215-22. PubMed ID: 3549727 [Abstract] [Full Text] [Related]
5. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E. Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095 [Abstract] [Full Text] [Related]
6. Human plasma platelet-activating factor acetylhydrolase. Purification and properties. Stafforini DM, Prescott SM, McIntyre TM. J Biol Chem; 1987 Mar 25; 262(9):4223-30. PubMed ID: 3558407 [Abstract] [Full Text] [Related]
7. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M. J Clin Invest; 1988 Dec 25; 82(6):1983-91. PubMed ID: 3198761 [Abstract] [Full Text] [Related]
8. Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus. Cederholm A, Svenungsson E, Stengel D, Fei GZ, Pockley AG, Ninio E, Frostegård J. Arthritis Rheum; 2004 Sep 25; 50(9):2869-76. PubMed ID: 15457454 [Abstract] [Full Text] [Related]
9. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. McCall MR, La Belle M, Forte TM, Krauss RM, Takanami Y, Tribble DL. Biochim Biophys Acta; 1999 Jan 29; 1437(1):23-36. PubMed ID: 9931415 [Abstract] [Full Text] [Related]
10. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM. J Biol Chem; 1991 Sep 05; 266(25):16667-73. PubMed ID: 1653245 [Abstract] [Full Text] [Related]
11. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162 [Abstract] [Full Text] [Related]
12. No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis. Denizot Y, Liozon E, Guglielmi L, Ly K, Soria P, Loustaud V, Vidal E, Jauberteau MO. Mediators Inflamm; 2003 Apr 05; 12(2):101-5. PubMed ID: 12775360 [Abstract] [Full Text] [Related]
13. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Imaizumi T, Satoh K, Yoshida H, Kawamura Y, Hiramoto M, Koyanagi M, Takamatsu S, Takamatsu M. Heart Vessels; 1990 Apr 05; 5(2):81-6. PubMed ID: 2354992 [Abstract] [Full Text] [Related]
14. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Mizono S, Shoji B, Takamatsu M. Prostaglandins; 1988 May 05; 35(5):685-98. PubMed ID: 3399678 [Abstract] [Full Text] [Related]
15. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. Ostermann G, Kostner GM, Gries A, Malle E, Till U. Haemostasis; 1989 May 05; 19(3):160-8. PubMed ID: 2744632 [Abstract] [Full Text] [Related]
16. The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). Pritchard PH, Chonn A, Yeung CC. Blood; 1985 Dec 05; 66(6):1476-8. PubMed ID: 4063532 [Abstract] [Full Text] [Related]
17. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells. Satoh K, Imaizumi T, Yoshida H, Takamatsu S. J Lab Clin Med; 1994 Feb 05; 123(2):225-31. PubMed ID: 8301198 [Abstract] [Full Text] [Related]
18. Platelet-activating factor acetylhydrolase activity in maternal, fetal, and newborn rabbit plasma during pregnancy and lactation. Maki N, Hoffman DR, Johnston JM. Proc Natl Acad Sci U S A; 1988 Feb 05; 85(3):728-32. PubMed ID: 3422455 [Abstract] [Full Text] [Related]
19. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor. Suzuki Y, Miwa M, Harada M, Matsumoto M. Eur J Biochem; 1988 Feb 15; 172(1):117-20. PubMed ID: 3345757 [Abstract] [Full Text] [Related]
20. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. Stafforini DM, Tjoelker LW, McCormick SP, Vaitkus D, McIntyre TM, Gray PW, Young SG, Prescott SM. J Biol Chem; 1999 Mar 12; 274(11):7018-24. PubMed ID: 10066756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]